NA
CCRN icon

Navellier & Associates’s Cross Country Healthcare CCRN Stock Holding History

Navellier & Associates’s Portfolio CCRN Stock Details CCRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-27,958
Closed -$785K – 317
2023
Q2 		$785K Buy
27,958
+945
+3% +$23.5K 0.15% 142
2023
Q1 		$603K Sell
27,013
-447
-2% -$11.7K 0.13% 152
2022
Q4 		$730K Buy
27,460
+1,601
+6% +$52.3K 0.15% 131
2022
Q3 		$734K Buy
+25,859
New +$665K 0.16% 126
2017
Q2 		– Sell
-11,241
Closed -$161K – 313
2017
Q1 		$161K Buy
+11,241
New +$165K 0.02% 274

Other funds holding CCRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Navellier & Associates's CCRN Position: Q3 2023 in Review

Navellier & Associates sold out of Cross Country Healthcare (CCRN) in Q3 2023, closing a stake of 27,958 shares — an estimated $785K sold.

Navellier & Associates first reported a position in CCRN in Q1 2017 and held it in 5 quarters. The position peaked at $785K in Q2 2023. 189 funds tracked by Wall St. Rank hold CCRN as of Q3 2023.

  • Navellier & Associates reported no remaining Cross Country Healthcare position as of Q3 2023 after selling out during the quarter.
  • Navellier & Associates sold 27,958 Cross Country Healthcare shares in Q3 2023, an estimated $785K.
  • Navellier & Associates first reported a position in Cross Country Healthcare in Q1 2017 and held it in 5 quarters.
  • Navellier & Associates's Cross Country Healthcare position peaked at $785K in Q2 2023.
  • 189 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q3 2023.

Based on Navellier & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.